-
Mashup Score: 1Unique Issues Facing Sexual and Gender Minorities in Cancer - 2 year(s) ago
Summary:. There are few resources available that help providers understand unique issues sexual and gender minority (SGM) people face related to cancer screening and care. This article helps fill the gap by providing some of the top-line issues providers and policymakers should know, as assembled by one of the leading experts in this field, the executive director of the National LGBT Cancer…
Categories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 5Community Advisory Board Application - 2 year(s) ago
We are researchers affiliated with the National LGBT Cancer Network and The National Cancer Institute partnering with The PRIDE Study to develop a survey to assess knowledge and attitudes about cancer screening, quality of life, and cancer care among members of the LGBTQIA+ community. We want to hear what you have to say about cancer. Through small group discussions, we hope to develop a survey…
Source: Google DocsCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 0
Dr. Morton’s research focuses on quantifying the risk of second cancers in different groups of cancer survivors, and elucidating the causes of second cancers.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 0Lene Veiga, Ph.D., biographical sketch and research interests - 2 year(s) ago
Dr. Veiga has extensive experience in the field of radiation protection and environmental and medical radiation research, with specialized expertise in radiation epidemiology and second cancers. She currently supports medical radiation initiatives studying survivor cohorts treated with radiotherapy as well as studies of diagnostic radiation and cancer risk.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 1Matthew M. Mille, Ph.D., staff scientist in DCEG. Biographical sketch and research interests. - 2 year(s) ago
Dr. Mille’s research interests center on computer simulations and metrology related to the delivery, detection, and dosimetry of ionizing radiation in medical imaging, radiation therapy, radiation protection, and homeland security.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 0Choonsik Lee, Ph.D., biographical sketch and research interests - 2 year(s) ago
Choonsik Lee, Ph.D. develops methods and tools to estimate radiation dose from medical exposures, including treatment and diagnostic tests, in order to generate reliable data for use in epidemiological studies of ionizing radiation and cancer risk.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 0Keith Griffin, Ph.D., M.S., Postdoctoral Fellow - 2 year(s) ago
Keith Griffin is helping to establish the computational dosimetry methods needed for future epidemiological studies on the use of radiation in medical procedures, as well as for the atomic bomb survivors at Hiroshima and Nagasaki.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 0
Dr. Morton’s research focuses on quantifying the risk of second cancers in different groups of cancer survivors, and elucidating the causes of second cancers.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 0Sergio Morato Rafet, Ph.D., Postdoctoral Fellow - 2 year(s) ago
Dr. Sergio Morato Rafet contributes to projects focused on Monte Carlo simulations and Deterministic Transport codes to calculate organ dose in radiotherapy, diagnostic imaging, and nuclear medicine, under the mentorship of Drs. Matthew Mille and Choonsik Lee.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 0
Dr. Drozdovitch’s main scientific interests include radiation dosimetry and dose reconstruction methods and analysis of uncertainties associated with radiation doses.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
RT @camcanepi: Unique Issues Facing Sexual and Gender Minorities in Cancer https://t.co/uK6H05O8az